Bariatric surgery volumes continue declining as GLP-1 prescriptions for obesity rise sharply from 2017 to 2025, per Ohio ...
People who have used GLP-1 medications—better known by their brand names like Ozempic, Mounjaro or Wegovy—have likely seen meaningful changes in their health, such as improved blood sugar, lower blood ...
GLP-1 medications are reshaping the weight management landscape — and beginning to take a bite out of bariatric surgery volumes in hospitals. Between 2022 and 2023, bariatric surgery rates fell 25.6% ...
The use of GLP 1s increased dramatically from 2018 to 2025 among patients eligible for metabolic and bariatric surgery in the ...
More than 40% of Americans are obese, according to the Centers for Disease Control and Prevention (CDC). And the epidemic isn't slowing down, resulting in millions of people suffering from health ...